Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Debt-free cannabis company set for next stage of growth

The following is a transcription of the above video, and The Market Online has edited it for clarity . Nextleaf Solutions (CSE:OILS) , is a debt-free cannabis processor known for its multi patented, scalable extraction technology. The company offers a diverse portfo...

Investor Update from One of the Most Innovative Leaders in Cannabis Science

Adastra Labs Holdings Ltd. ( CSE.XTRX , OTC: XTXXF , Forum ) is a leading manufacturer and supplier of innovative ethno-botanical and cannabis science products designed for the adult-use and medical markets and forward-looking therapeutic applications. This unique compa...

Buzz on the Bullboards: Cannabis Tops Health Care

(Image via HEXO Corp.) How high can we get? This past week, it has been the question on the minds of traders, when a market roller coaster saw indexes hit record highs while company earnings saw major names soar and fall in equal measure. Tapping into the larges...

Intra-Cellular Therapies Shares Rise 200% on FDA Approval of Adult Schizophrenia Drug

Shares of Intra-Cellular Therapies opened greater than 100% higher today after the company reported that the FDA approved its antipsychotic CAPLYTA® (lumateperone) drug for the treatment of schizophrenia in adults. This morning a biopharmaceutical company foc...

Buzz on the Bullboards: Winners & Losers in Energy, Tech, & Cannabis

(Hexo Corp. stock chart – May 2021 to August 2021. Click to enlarge) Markets on Bay Street and Wall Street have seen a tumultuous close ride as we near the end of the summer season. Three of the biggest contributors to recent growth (and recent dips) are the tech, e...

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report. In an Aug. 20 research note, analyst Ed Arce reported that H.C. Wainwright & Co. raised its target price on Nabriva Therapeutics Plc (NBRV:NASDAQ) to $8 per sh...

E*TRADE, flatex, wallstreet:online: the winners of the Corona Pandemic

Since the beginning of the Corona Pandemic, economic life has tended to shift from the offline to the online world. The winners of this trend are e-commerce service providers, such as Amazon and HelloFresh, and above all the operators of online brokerage platforms. This phenom...

The Dales Report panelists agree on this vote: Way to go, Ohio

Welcome to the Trade To Black podcast on Stockhouse.com . In the episode in the above video, Shadd Dales, Anthony Varrell and Benjamin Smith talk in-depth about the following stories and more: Ohio voters approve the legalization of adult use cannabis ...

Discover Online Value Through Advanced Intelligence Functionality

There are more than three billion social media users around the world. A company can only truly reach its full potential if it understands the depth of its online presence to connect with this audience; one Canadian artificial intelligence and machine learning Company ...

Buzz on the Bullboards: Defending Voter Rights

(Image via @porkchopchili.) There is one burning topic among Stockhouse’s Bullboards of late … the showdown for the White House. Early voting is underway in the US for what is a presidential election for the ages and as we all know, there has been ...
1 2 3 4 5 6 7 8 9 10 ...